“Quackery” that saves lives

I’m used to being a target of mainstream medicine. I can’t even count the number of times I’ve been called a “quack.”

Let me give you just one example…

For decades I’ve been treating my patients with a proven therapy. The FDA approved it way back in 1953. I use it to help my patients detox from mercury, lead, cadmium and other heavy metals. In fact, more than 100,000 people get this therapy every year in the U.S.

But mainstream doctors still laugh at the idea of this treatment and think it’s pure bunk.

I’m talking about intravenous (IV) chelation.

Even though I’ve been mocked, I’ve never stopped offering it to my patients. I can’t ethically abandon a treatment that works wonders. I’ve found it’s especially effective for my diabetic patients with heart disease.

And now the National Institutes of Health (NIH) is finally starting to come around. Let me explain…

About 15 years ago, a Harvard cardiologist named Dr. Gervasio Lamas set out to prove chelation was quackery. In 2002, he launched a study of more than 1,700 heart attack survivors. It involved 134 research sites. The patients were randomly assigned to receive IV chelation or a placebo.

After seven years, Dr. Lamas was shocked by his own results.

Compared to placebo, patients who received chelation had a 26% lower risk of heart complications. That included things like a second heart attack, stroke or bypass surgery.1

The results for diabetic patients were even more dramatic. They had a 49% lower risk of heart complications. And chelation cut the risk of death among diabetics by half.

It makes perfect sense that chelation would heal heart disease. You see, heavy metals like cadmium and lead can damage your circulatory system. They inactivate your body’s antioxidant defenses. They damage the cells that line the blood vessels. They can narrow arteries and lead to atherosclerosis. All of that can lead to heart attacks.

Dr. Lamas’ results sent shockwaves through the medical world. Most heahrt doctors rejected the study.

But the NIH took notice. They have now awarded Dr. Lamas’ group a $37 million grant for a 5-year follow-up study. Dr. Lamas hopes if the new study is positive, IV chelation may become a first-line therapy for heart disease.

I hope he’s right. But I know how Big Pharma works. They will never accept that IV chelation saves lives. They have too much money at stake in their statins, beta-blockers, ACE inhibitors, and other blockbuster heart drugs. And they can’t make money on chelation because it can’t be patented.

I’m not waiting for mainstream medicine to come around. I continue to offer safe IV chelation to my patients here at the Sears Institute for Anti-Aging Medicine. It’s the quickest way to rid your body of the heavy metals and toxins you’ve accumulated over the years.

IV chelation is a simple procedure. I inject calcium disodium EDTA directly into your bloodstream. It’s painless. And in no time, EDTA grabs heavy metals and toxins and pulls them out.

It works fast. After one 10-minute session, you’re done and on your way. Patients tell me they feel better almost immediately.

Over the years, I’ve also found that patients get the best results when we combine IV and oral chelation. But even if you don’t do the IV part, you can still get great results with oral chelation at home.

Oral chelation is done with an agent called DMSA. It comes in pill form.

First, you’ll be tested to see what heavy metals are in your system. Then you’ll be given a prescription for DMSA. Your exact dosage will be based on your weight, and will usually be administered over the course of several months.

Call the Sears Institute for Anti-Aging Medicine at 561-784-7852 to schedule IV chelation or to arrange to do oral chelation at home. Oral chelation patients must come in for an office visit before any prescription can be written.

To Your Good Health,

Al Sears, MD

Al Sears, MD, CNS

1.Lamas GA, Goertz C, Boineau R, et al. “Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction: The TACT Randomized Trial.” JAMA. 2013;309(12):1241-1250.